Estradiol levels in menopause: what the number can and cannot tell you

Why the number moves so much

In a regular cycle, estradiol already varies several-fold between the start of a period and the days before ovulation. In perimenopause that variation becomes larger and loses its predictable shape.

A woman can have an estradiol level above the premenopausal range one week and a postmenopausal level three weeks later. Both results are real and neither describes her situation.

This is the core reason hormone testing fails to answer the perimenopause question. The problem is not laboratory accuracy; it is that the quantity being measured is genuinely unstable.

What guidance says

NICE advises diagnosing perimenopause in women over 45 on symptoms and cycle pattern without laboratory tests, and specifically advises against measuring estradiol or FSH for this purpose in that group.

The practical consequence is the one worth carrying into an appointment: a normal estradiol at 47 does not mean this is not perimenopause. If a normal result is used to close the conversation, that conclusion does not follow from that test.

Where measuring it does help

• Under 40, where the question is whether primary ovarian insufficiency is present, and estradiol alongside repeated FSH is part of the diagnosis
• Between 40 and 45, where testing is more reasonable than above 45 though still interpreted cautiously
• Where there are no periods to assess — after hysterectomy, or with a hormonal intrauterine system
• Occasionally on treatment, to check absorption where symptoms persist despite an apparently adequate dose, particularly with patches or gels
• In specialist settings, monitoring specific treatments where a target range matters

Dose is guided by symptoms, not by a target level

Standard practice does not titrate hormone therapy to a blood level. The dose is adjusted according to symptom response and tolerability.

There is no established optimal estradiol level for treating menopausal symptoms, and chasing a number risks either overtreating someone who feels well or undertreating someone who does not, because response at a given level varies widely between individuals.

This is one of the clearest differences between mainstream prescribing and commercial hormone-optimisation services, which frequently test and titrate to a target.

About saliva testing

Salivary hormone testing is widely marketed and is not supported by professional bodies for assessing menopausal status or guiding treatment.

Salivary levels do not correlate reliably with blood levels or tissue activity, and results vary with collection technique, time of day and contamination. A panel of salivary results is not a sound basis for a treatment plan.

When to see someone

If you are over 45 with typical symptoms, you do not need a test to be taken seriously, and it is reasonable to say so if one is used to dismiss you.

Ask for testing if you are under 45, if you have no periods to track, or if symptoms persist on treatment despite an apparently adequate dose — that last case is where a level genuinely changes what happens next.